1. Latest News
  2. Submit Press Release

Keep up to speed with the latest advances in Controlled-Release

Overcome Formulation challenges for oral delivery of peptide and lipid-based therapeutics

Jan. 20, 2012 - PRLog -- Examining the latest developments in nanomedicine, join SMi’s ninth annual Controlled-Release conference, featuring fresh presentations from leading companies in this interesting field.  Topics include enhancing in vivo circulation time, extending dissolution kinetics, and improving delivery with drug-porous nanocarriers, lipid-based compounds and biologics.  Whether your interests lie in formulation, particle design or drug delivery book now to secure your place!  

6 Key reasons why you should attend this interesting event include:

•    Increasing patent revenue for oral and non oral drug delivery products
•    Extending product lifecycles through reformulation to keep market share
•    Accelerating to phase III faster with lipid-based compounds
•    Improving manufacturing efficiency and scale-ability for miniaturisation and bead milling
•    Reducing costs with in silico applications to maximise commercial development
•    Implementing lessons for ADMET testing when using nanoparticles

There will also be two interactive pre-conference workshops held on the 27th March 2012 on.....

A.   Accelerating first-in-human studies (FIH) with lipid-based formulations
Hosted by: David J. Hauss, Principal, Hauss Associates
Hassan Benameur, Senior Director Pharmaceutical Sciences, Capsugel
Senior Representative, Gattefossé

B.    A trip through the life and work of a patent
Hosted by: Jonathan Couchman, Partner, Harrison Goddard Foote (HGF) and Martyn Fish, Partner, HGF Law

For more information and to book your place visit http://www.smi-online.co.uk/controlledrelease38.asp

Alternatively, contact Ninica Hussain at Tel: +44 (0)20 7827 6115 or Email: nhussain@smi-online.co.uk

--- End ---

Click to Share

Contact Email:
***@smi-online.co.uk Email Verified
Source:SMi Group
Location:United Kingdom
Tags:Formulation, Extended Release, Drug Delivery, Parenteral Drug Delivery, Transdermal Drug Delivery
Verified Account Email Address
Verified Account Phone Number

Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “


Trending News...

Like PRLog?
Click to Share